StonvexLoading…
StonvexStonvexStonvexCore line items from ATRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $120.77M | $128.94M | $96.19M | $56.00M |
Operating Income | $35.86M | $-83.44M | $-71.23M | $-49.48M |
Net Income | $32.69M | $-85.40M | $-72.71M | $-19.05M |
EPS (Diluted) | $2.57 | $-11.41 | $-11.34 | $-8.64 |
Total Assets | $20.23M | $109.10M | $142.71M | $117.28M |
Total Liabilities | $58.74M | $206.38M | $233.25M | $228.15M |
Cash & Equivalents | $8.48M | $25.03M | $46.45M | $31.31M |
Free Cash Flow OCF − CapEx | $-50.94M | $-68.96M | $-44.40M | $-40.41M |
Shares Outstanding | 7.32M | 5.86M | 5.74M | 4.90M |